1. Un-audited Standlone Financial Results (Ind AS) for the quarter and nine months ended 31 December 2025 2. Limited Review Report issued by the Statutory Auditor of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Microse India reported extremely weak Q3 FY26 results with revenue from operations of just ₹3.14 lakhs versus nil in Q3 FY25. For the nine months ended December 2025, revenue from operations was negative at ₹(100.07) lakhs, indicating that sales returns and adjustments exceeded sales. Total revenue for 9M FY26 stood at ₹(99.87) lakhs against ₹0.15 lakhs in 9M FY25, showing a near-total collapse of the business compared to ₹136.27 lakhs for the full FY25. The company posted a loss after tax of ₹158.73 lakhs for 9M FY26, sharply worse than a loss of ₹14.07 lakhs in 9M FY25 and a profit of ₹95.85 lakhs in FY25. Total expenses for 9M FY26 were ₹58.86 lakhs, dominated by purchases of ₹19.58 lakhs, inventory write-downs of ₹24.24 lakhs, and employee costs of ₹8.78 lakhs. The statutory auditor, Todarwal & Todarwal LLP, issued an unmodified limited review report with no qualifications.
The results paint a grim picture for shareholders — revenue has effectively disappeared and losses have ballooned tenfold year-on-year, suggesting serious operational and going-concern concerns that could weigh heavily on the stock. Investors should watch for any fundraising, restructuring, or board-level action in coming quarters.